NCT06783530

Brief Summary

This study aimed to evaluate the psychological and clinical outcomes of patients undergoing splint therapy with or without enhanced doctor-patient communication in the management of temporomandibular disorders (TMDs). The study compared treatment approaches to determine their impact on patient satisfaction and clinical results.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
435

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2024

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 20, 2025

Completed
Last Updated

January 20, 2025

Status Verified

January 1, 2025

Enrollment Period

1.3 years

First QC Date

January 9, 2025

Last Update Submit

January 14, 2025

Conditions

Keywords

Splint TherapyDoctor-Patient CommunicationNon-Surgical TMD TreatmentTMDs management

Outcome Measures

Primary Outcomes (4)

  • Change in Depression, Anxiety, and Stress levels

    Depression, anxiety, and stress levels was measured using the 10-item Depression, Anxiety, and Stress Scale (DASS-10) at baseline and after six months of therapy. The DASS-10 comprises 10 items, each rated on a 4-point Likert scale ranging from 0 ("Did not apply to me at all") to 3 ("Applied to me very much or most of the time"). * Minimum value: 0 * Maximum value: 30 * Interpretation: Higher scores indicate worse psychological outcomes.

    Baseline to 6 months.

  • Change in Interincisal Mouth Opening

    Maximum interincisal mouth opening was measured at baseline and after six months of therapy using a calibrated caliper.

    Baseline to 6 months.

  • Change in Intra-articular pain (IAP)

    Intra-articular pain was assessed at baseline and after six months using the Visual Analog Scale (VAS) for pain intensity. The scale ranged from 0 to 10, where: * Minimum value: 0 (No pain) * Maximum value: 10 (Worst possible pain).

    Baseline to 6 months.

  • Change in Joint Sound Presence and Characteristics

    Joint Sounds were measured in scores from 0 to 5, where 0 = no joint sound, 1 = Joint noise on occasion, 2 = palpable clicking, 3 = audible clicking, 4 = absence of previous clicking (closed lock), and 5 = crepitation. Assessment of the presence and characteristics of joint sounds was performed at baseline and after six months of therapy.

    Baseline to 6 months.

Secondary Outcomes (2)

  • Change in Masticatory Muscle Pain Intensity

    Baseline to 6 months.

  • Patient Satisfaction with Treatment

    From 6 months to 1-year post-intervention.

Study Arms (2)

Splint Therapy with Enhanced Doctor-Patient Communication

EXPERIMENTAL

Participants in this arm received splint therapy along with structured doctor-patient communication to improve treatment outcomes.

Behavioral: Splint Therapy with Enhanced Doctor-Patient Communication

Standard Splint Therapy

ACTIVE COMPARATOR

Participants in this group received standard splint therapy for the management of temporomandibular disorders (TMD). The splint was fitted and adjusted by a qualified clinician, and participants was monitored for outcomes such as pain reduction, jaw function, and patient satisfaction.

Device: Splint Therapy

Interventions

A structured communication protocol aimed at improving doctor-patient interaction and treatment adherence.

Splint Therapy with Enhanced Doctor-Patient Communication

A custom-fitted occlusal splint designed to alleviate symptoms of temporomandibular disorders (TMD).

Standard Splint Therapy

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • patients complaining of pain in the orofacial region (either arthrogenous and/or myogenous TMD) in the last 3 months, who never underwent any type of treatment for TMD's.
  • Age ≥16 years.

You may not qualify if:

  • patients who have already undergone any treatment for TMD's, edentulous patients,
  • patients with any systemic disease that could cause joint and/or muscle changes,
  • patients who were undergoing drug treatment for the condition, current pregnancy, or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Mansoura University

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Location

Related Publications (2)

  • de Barros Pascoal AL, de Freitas RFCP, da Silva LFG, Oliveira AGRC, Dos Santos Calderon P. Effectiveness of Counseling on Chronic Pain Management in Patients with Temporomandibular Disorders. J Oral Facial Pain Headache. 2020 Winter;34(1):77-82. doi: 10.11607/ofph.2163. Epub 2019 Apr 12.

    PMID: 30978270BACKGROUND
  • Haggag MA, Ibrahim CRM, Badawy ST. Psychological and Clinical Outcomes After Splint Therapy With Versus Without Doctor-Patient Communication Concept in the Management of TMDs: A Randomised Controlled Clinical Trial. J Oral Rehabil. 2025 Oct;52(10):1651-1663. doi: 10.1111/joor.14005. Epub 2025 May 19.

Related Links

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Study Officials

  • Soaad Tolba Badawy, Lecturer of OMFS, MU

    Faculty of dentistry, Mansoura university

    PRINCIPAL INVESTIGATOR
  • Mai Ahmed Haggag, Assistant Professor of OMFS

    Faculty of dentistry, Mansoura university

    PRINCIPAL INVESTIGATOR
  • Christine Raouf Micheal, Assistant Professor

    Prosthodontics Department, Faculty of dentistry, Mansoura university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The allocation was concealed from participants and the statistician performing the data analysis to minimize bias. However, the clinician administering the intervention was aware of the patient's allocation to ensure appropriate treatment delivery.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study used a parallel assignment model with two groups: one receiving standard splint therapy and the other receiving splint therapy with enhanced doctor-patient communication.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
lecturer of oral and maxillofacial department, faculty of dentistry, Mansoura university

Study Record Dates

First Submitted

January 9, 2025

First Posted

January 20, 2025

Study Start

July 1, 2023

Primary Completion

October 15, 2024

Study Completion

October 30, 2024

Last Updated

January 20, 2025

Record last verified: 2025-01

Locations